A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin glulisine
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Prednisolone phosphate
The excretion of Prednisolone phosphate can be decreased when combined with Dolutegravir.
Insulin glulisine
Tenofovir alafenamide
The excretion of Tenofovir alafenamide can be decreased when combined with Dolutegravir.
Insulin glulisine
Relebactam
The excretion of Relebactam can be decreased when combined with Dolutegravir.
Insulin glulisine
Edaravone
The excretion of Edaravone can be decreased when combined with Dolutegravir.
Insulin glulisine
Eluxadoline
The excretion of Eluxadoline can be decreased when combined with Dolutegravir.
Insulin glulisine
Avibactam
The excretion of Avibactam can be decreased when combined with Dolutegravir.
Insulin glulisine
Cefaloridine
The excretion of Cefaloridine can be decreased when combined with Dolutegravir.
Insulin glulisine
Calcium polycarbophil
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium polycarbophil.
Insulin glulisine
Calcium pangamate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium pangamate.
Insulin glulisine
Calcium lactate gluconate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium lactate gluconate.
Insulin glulisine
Calcium lactate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium lactate.
Insulin glulisine
Calcium Phosphate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium Phosphate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3